Ken‐ichi Ohba

2.6k citations
93 papers · 2.2k indexed · h-index 28
Topics
Hepatitis C virus research (33 papers)Hepatitis B Virus Studies (25 papers)Liver Disease Diagnosis and Treatment (17 papers)
Partner nations
JapanUnited StatesIndia

In The Last Decade

Ken‐ichi Ohba

91 papers receiving 2.1k citations

Peers

Ken‐ichi Ohba
Comparison fields: 5 of 111
  • Epidemiology 1.2k
  • Hepatology 1.1k
  • Molecular Biology 345
  • Physiology 298
  • Infectious Diseases 171
Replace Janine McMillan with:
Janine McMillan Australia
Vikas Chandhoke United States
Kurt J. Williams United States
Gang Ning United States
Shogo Watanabe Japan
Ruqi Tang China
Wen Wang China
Dong‐Mi Shin South Korea
Kuiyang Zheng China
Kirk J. Maurer United States
Ken‐ichi Ohba relative to Janine McMillan Australia Janine McMillan's profile →
Citations per field
00.5×1.5×2.3×
Janine McMillan · 1×
Citations per year

Countries citing papers authored by Ken‐ichi Ohba

Since Specialization
Citations

This map shows the geographic impact of Ken‐ichi Ohba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐ichi Ohba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐ichi Ohba more than expected).

Fields of papers citing papers by Ken‐ichi Ohba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐ichi Ohba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐ichi Ohba. The network helps show where Ken‐ichi Ohba may publish in the future.

Co-authorship network of co-authors of Ken‐ichi Ohba

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐ichi Ohba. A scholar is included among the top collaborators of Ken‐ichi Ohba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐ichi Ohba. Ken‐ichi Ohba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 36
3 4
4 36
5 17
6 16
7 5
8 6
9 13
10 33
11 21
12 30
13 93
14 7
15 20
16 1
17 82
18 110
19 5
20 11

About Ken‐ichi Ohba

Ken‐ichi Ohba is a scholar working on Hepatology, Epidemiology and Developmental Biology, having authored 93 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatitis C virus research (33 papers), Hepatitis B Virus Studies (25 papers) and Liver Disease Diagnosis and Treatment (17 papers). The work is most often cited by research in Hepatology (1.1k citations), Epidemiology (1.2k citations) and Virology (75 citations). Ken‐ichi Ohba has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Masashi Mizokami, Etsuro Orito, Takashi Gojobori, Johnson Y.N. Lau, Kazuho Ikeo, Hisayoshi Ohta, M. Mizokami, Toshimasa Yoshioka, Takamura Muraki and Yasuo Ina. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026